| Nicholas Kaiwa George, MD | |
|
400 N Pepper Ave, Colton, CA 92324-1819 | |
| (530) 945-8885 | |
| Not Available |
| Full Name | Nicholas Kaiwa George |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 400 N Pepper Ave, Colton, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346801396 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD61422119 (Washington) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Entity Name | Cep America Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447484274 PECOS PAC ID: 6608056171 Enrollment ID: O20130213000571 |
News Archive
With almost half of respondents saying they believe a sneeze travels eight feet or more, one might think you would be sick all the time. But a recent national survey of 1,017 U.S. adult men and women (age 18+) conducted by Matrixx Initiatives, Inc., maker of Zicam, found a majority of Americans polled surprisingly saw this cold and flu season as "about the same" (42%) or only "slightly worse" (21%) from last year, despite all the hype this past fall around H1N1.
BioDelivery Sciences International, Inc. has received a $1.3 million grant from the Walter Reed Army Institute of Research for Bioral Amphotericin B, an oral formulation of the fungicidal treatment amphotericin B in BDSI's patented Bioral drug delivery technology, to further study the formulation in the treatment of Cutaneous Leishmaniasis.
Great River Medical Center's Board of Directors has approved construction of a new long-term-care center on the hospital's West Burlington, Iowa campus. It will replace the existing Klein Center at 2910 Madison Ave., Burlington, Iowa.
Vitamin D and marine omega-3 fatty acids - also known as fish oil - are purported to have many health benefits, including reducing systemic inflammation.
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Kaiwa George, MD 400 N Pepper Ave, Colton, CA 92324-1819 Ph: () - | Nicholas Kaiwa George, MD 400 N Pepper Ave, Colton, CA 92324-1819 Ph: (530) 945-8885 |
News Archive
With almost half of respondents saying they believe a sneeze travels eight feet or more, one might think you would be sick all the time. But a recent national survey of 1,017 U.S. adult men and women (age 18+) conducted by Matrixx Initiatives, Inc., maker of Zicam, found a majority of Americans polled surprisingly saw this cold and flu season as "about the same" (42%) or only "slightly worse" (21%) from last year, despite all the hype this past fall around H1N1.
BioDelivery Sciences International, Inc. has received a $1.3 million grant from the Walter Reed Army Institute of Research for Bioral Amphotericin B, an oral formulation of the fungicidal treatment amphotericin B in BDSI's patented Bioral drug delivery technology, to further study the formulation in the treatment of Cutaneous Leishmaniasis.
Great River Medical Center's Board of Directors has approved construction of a new long-term-care center on the hospital's West Burlington, Iowa campus. It will replace the existing Klein Center at 2910 Madison Ave., Burlington, Iowa.
Vitamin D and marine omega-3 fatty acids - also known as fish oil - are purported to have many health benefits, including reducing systemic inflammation.
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).
› Verified 6 days ago
Eugene Lawrence Kwong, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 N. Pepper Avenue, Colton, CA 92324 Phone: 909-580-1400 | |
Gregory M. Fenati, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 858-344-7049 | |
Carol Hyeun Lee, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 N. Pepper Avenue, Colton, CA 92324 Phone: 909-580-1400 | |
Dr. Vikram Raj, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 N Pepper Ave Ste 107, Colton, CA 92324 Phone: 909-580-1802 | |
Robert Sexton Kollen, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 N. Pepper Avenue, Colton, CA 92324 Phone: 909-580-1400 | |
Leigh Elizabeth Avera, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 909-580-1000 | |
Kenneth Paul Takaki, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 909-580-6370 |